ESSA Pharma Inc. - Common Shares, no par value per share (EPIX)
CUSIP: 29668H708
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 47,601,550
- Total 13F shares
- 33,417,334
- Share change
- -3,981,641
- Total reported value
- $60,814,684
- Price per share
- $1.82
- Number of holders
- 49
- Value change
- -$15,060,697
- Number of buys
- 22
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 29668H708?
CUSIP 29668H708 identifies EPIX - ESSA Pharma Inc. - Common Shares, no par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29668H708:
Top shareholders of EPIX - ESSA Pharma Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) as of Q3 2022
As of 30 Sep 2022,
ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,417,334 shares.
The largest 10 holders included
BVF INC/IL, Bellevue Group AG, Soleus Capital Management, L.P., Avidity Partners Management LP, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, PFM Health Sciences, LP, RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and Frazier Life Sciences Management, L.P..
This page lists
49
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
55
Q3 2022 holders
49
Holder diff
-6
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.